Targeting EGFR in non-small-cell lung cancer

被引：23
|
作者：
Doroshow, JH [1 ]
机构：
[1] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 02期
关键词：
D O I：
10.1056/NEJMe058113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 202
页数：3
相关论文
共 50 条
  • [21] Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer
    Rangachari, Deepa
    Brahmer, Julie R.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (04) : 580 - 594
  • [22] TARGETING MEK AND BRAF IN NON-SMALL-CELL LUNG CANCER (NSCLC)
    Planchard, D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S23 - S23
  • [23] Targeting the MET gene for the treatment of non-small-cell lung cancer
    Gelsomino, F.
    Facchinetti, F.
    Haspinger, E. R.
    Garassino, M. C.
    Trusolino, L.
    De Braud, F.
    Tiseo, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (02) : 284 - 299
  • [24] Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer
    Deepa Rangachari
    Julie R. Brahmer
    Current Treatment Options in Oncology, 2013, 14 : 580 - 594
  • [25] EGFR mutation and non-small-cell lung cancer: EGFR test, cost and quality of life
    Thongprasert, Sumitra
    LUNG CANCER MANAGEMENT, 2012, 1 (03) : 169 - 172
  • [26] Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Planchard, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1780 - 1782
  • [27] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
    Fang, Shu
    Wang, Zhehai
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611
  • [28] Treatment choice in EGFR-mutant non-small-cell lung cancer
    Brueckl, Wolfgang M.
    LANCET ONCOLOGY, 2017, 18 (11): : 1425 - 1426
  • [29] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
    Rafael Rosell
    Teresa Morán
    Enric Carcereny
    Vanessa Quiroga
    Miguel Ángel Molina
    Carlota Costa
    Susana Benlloch
    Miquel Tarón
    Clinical and Translational Oncology, 2010, 12 : 75 - 80
  • [30] EGFR degraders in non-small-cell lung cancer: Breakthrough and unresolved issue
    Shen, Jiayi
    Chen, Liping
    Liu, Jihu
    Li, Anzhi
    Zheng, Luyin
    Chen, Sheng
    Li, Yongdong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (04)
12345